Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
Status:
Terminated
Trial end date:
2008-12-15
Target enrollment:
Participant gender:
Summary
RATIONALE: Pilocarpine may help to relieve dry mouth in patients receiving opioids for cancer
therapy. It is not yet known whether pilocarpine is more effective than no further treatment
for this condition.
PURPOSE: Randomized phase III trial to determine the effectiveness of pilocarpine in treating
patients who have dry mouth caused by opioids.